Compare Alphabet Inc Class A (GOOGL) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alphabet Inc Class A vs GSK plc — how do they compare? Alphabet Inc Class A trades at $344.9 (market cap $4.20T), while GSK plc trades at $50.56 (market cap $101.13B). The key difference: Alphabet Inc Class A is far larger — about 41.5× GSK plc's market cap, and GSK plc pays the higher dividend (3.61%). Which is the better fit depends on your goals.
| GOOGL | GSK | |
|---|---|---|
Market Cap | $4.20T | $101.13B |
Sector | Media | Health |
52-Week High | $402.62 | $61.18 |
52-Week Low | $199.32 | $38.96 |
Enterprise Value | $4.08T | $121.57B |
Dividend Yield | 0.26% | 3.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOGL) trades at $343.8, down 3.84% over 24 hours, with a bearish technical signal but strong fundamentals. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight robust profit growth, with net income reaching $132.17 billion in 2025. The stock faces near-term pressure from technical indicators but benefits from AI-driven revenue expansion and a consensus analyst price target of $426.28, suggesting significant upside potential.
The outlook remains positive due to solid earnings performance and AI investments, though risks include antitrust scrutiny and market volatility. With 85% of analysts rating it a buy, GOOGL offers long-term growth opportunities, but investors should monitor competitive and regulatory challenges that could impact valuation.
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
